SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-067187
Filing Date
2020-03-09
Accepted
2020-03-09 16:18:58
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d894337ds3.htm S-3 251737
2 EX-4.2 d894337dex42.htm EX-4.2 298203
3 EX-5.1 d894337dex51.htm EX-5.1 23311
4 EX-23.2 d894337dex232.htm EX-23.2 1594
5 GRAPHIC g894337dsp001.jpg GRAPHIC 12703
6 GRAPHIC g894337g0305102704065.jpg GRAPHIC 1843
7 GRAPHIC g894337g08i91.jpg GRAPHIC 42650
  Complete submission text file 0001193125-20-067187.txt   650696
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237033 | Film No.: 20698197
SIC: 2834 Pharmaceutical Preparations